Capital Investment Advisory Services’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.85M Buy
29,988
+1,464
+5% +$171K 0.24% 100
2026
Q1
$3.43M Buy
28,524
+552
+2% +$63.7K 0.25% 95
2025
Q4
$2.94M Sell
27,972
-443
-2% -$41.6K 0.21% 112
2025
Q3
$2.38M Sell
28,415
-275
-1% -$22.6K 0.19% 131
2025
Q2
$2.27M Buy
28,690
+79
+0.3% +$6.28K 0.19% 125
2025
Q1
$2.57M Buy
28,611
+3,311
+13% +$309K 0.23% 104
2024
Q4
$2.52M Buy
25,300
+510
+2% +$52.6K 0.24% 92
2024
Q3
$2.82M Sell
24,790
-1,987
-7% -$236K 0.27% 84
2024
Q2
$3.31M Sell
26,777
-708
-3% -$91.2K 0.34% 72
2024
Q1
$3.63M Sell
27,485
-1,060
-4% -$131K 0.39% 58
2023
Q4
$3.11M Sell
28,545
-528
-2% -$54.8K 0.29% 64
2023
Q3
$2.99M Buy
29,073
+521
+2% +$56.2K 0.29% 60
2023
Q2
$3.29M Buy
28,552
+332
+1% +$37.7K 0.33% 55
2023
Q1
$3M Sell
28,220
-1,336
-5% -$144K 0.35% 57
2022
Q4
$3.28M Buy
29,556
+940
+3% +$96.1K 0.39% 50
2022
Q3
$2.46M Buy
28,616
+580
+2% +$51.8K 0.32% 61
2022
Q2
$2.56M Sell
28,036
-1,714
-6% -$152K 0.31% 64
2022
Q1
$2.44M Sell
29,750
-1,018
-3% -$80.3K 0.27% 76
2021
Q4
$2.36M Buy
30,768
+2,586
+9% +$206K 0.28% 80
2021
Q3
$2.12M Sell
28,182
-2,171
-7% -$165K 0.27% 76
2021
Q2
$2.36M Sell
30,353
-2,288
-7% -$170K 0.3% 72
2021
Q1
$2.4M Buy
32,641
+1,673
+5% +$123K 0.34% 70
2020
Q4
$2.42M Buy
30,968
+2,132
+7% +$163K 0.36% 64
2020
Q3
$2.28M Sell
28,836
-1,490
-5% -$117K 0.43% 53
2020
Q2
$2.24M Buy
30,326
+286
+1% +$21.5K 0.45% 54
2020
Q1
$2.21M Buy
30,040
+11,116
+59% +$874K 0.54% 36
2019
Q4
$1.64M Sell
18,924
-305
-2% -$25.1K 0.44% 46
2019
Q3
$1.54M Sell
19,229
-885
-4% -$70.9K 0.43% 49
2019
Q2
$1.56M Buy
20,114
+3,657
+22% +$280K 0.47% 41
2019
Q1
$1.31M Buy
16,457
+11
+0.1% +$823 0.49% 39
2018
Q4
$1.2M Sell
16,446
-1,064
-6% -$75.1K 0.51% 40
2018
Q3
$1.19M Buy
17,510
+711
+4% +$45.3K 0.56% 44
2018
Q2
$973K Buy
16,799
+503
+3% +$28.4K 0.49% 51
2018
Q1
$847K Buy
16,296
+4,240
+35% +$229K 0.47% 47
2017
Q4
$647K Buy
12,056
+1,985
+20% +$110K 0.38% 65
2017
Q3
$615K Sell
10,071
-120
-1% -$7.28K 0.38% 64
2017
Q2
$623K Buy
10,191
+500
+5% +$30.4K 0.41% 64
2017
Q1
$588K Buy
9,691
+60
+0.6% +$3.64K 0.43% 64
2016
Q4
$541K Buy
+9,631
New +$564K 0.47% 59

Other funds holding MRK

Capital Investment Advisory Services's MRK Position: Q2 2026 in Review

Capital Investment Advisory Services increased its Merck (MRK) stake by 5.1% in Q2 2026, buying an estimated $171K and bringing the position to 29,988 shares worth $3.85M. The position accounts for 0.24% of the portfolio, ranked #100.

Capital Investment Advisory Services first reported a position in MRK in Q4 2016 and has held it in 39 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Capital Investment Advisory Services held 29,988 shares of Merck worth $3.85M as of Q2 2026.
  • Capital Investment Advisory Services bought 1,464 Merck shares in Q2 2026, an estimated $171K.
  • Merck made up 0.24% of Capital Investment Advisory Services's portfolio in Q2 2026, its #100 holding.
  • Capital Investment Advisory Services first reported a position in Merck in Q4 2016 and has held it in 39 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Capital Investment Advisory Services's 13F filing for Q2 2026, filed 23 Jul 2026.